Two items of interest:
The first is the report of the U.S. Department of Justice’s Task Force on Intellectual Property. Must reading (and particularly so because they quote the CMPI report on the almost unobstructed growth of counterfeit prescription medicines).
The second is the latest report out of Europe on the same topic.
Both can be found at: